Analyses from the American Medical Association determined the potential Aetna-Humana and Anthem-Cigna mergers will diminish competition in at least 23 states and more than 100 metropolitan areas.
Concerns with the proposed mergers of Anthem and Cigna and of Aetna and Humana have already been raised in letters from the American Hospital Association to HHS Secretary Sylvia Mathews Burwell.
Now analyses from the American Medical Association (AMA) on the potential mergers, which would reduce the top 5 health insurers in the United States down to just 3, reveal just how much competition in local health insurance markets could be reduced. Given the results of the analyses, the AMA is urging regulators to carefully review the proposed mergers and preserve competition.
"A lack of competition in health insurer markets is not in the best interests of patients or physicians," AMA President Steven J. Stack, MD, said in a statement. "If a health insurer merger is likely to erode competition, employers and patients may be charged higher than competitive premiums, and physicians may be pressured to accept unfair terms that undermine their role as patient advocates and their ability to provide high-quality care.”
One analysis found that the Anthem-Cigna merger would likely enhance market power in 10 states: New Hampshire, Indiana, Connecticut, Maine, Virginia, Georgia, Colorado, Montana, Nevada, and Kentucky. These states represent a majority of the 14 total states in which Anthem is licensed to provide commercial coverage. Furthermore, the merger raises competitive concerns and warrants scrutiny in Ohio, California, New York, and Wisconsin.
Looking at the more local level, the AMA determined that the Anthem-Cigna merger would enhance market power in 85 metropolitan areas within 13 states, plus the merger would raise significant concerns in additional markets. In total, the merger would diminish competition in 111 metropolitan areas within all 14 states that Anthem currently operates.
The Aetna-Humana merger will have less of an impact. In the second analysis, AMA found a merger between Aetna and Humana would enhance market power in only Kentucky and raise significant competitive concerns in Texas, Georgia, Utah, and Florida. In total the merger would diminish competition in 58 metropolitan areas within 14 states: Arizona, Florida, Georgia, Illinois, Indiana, Kentucky, Louisiana, Mississippi, Ohio, Tennessee, Texas, Utah, Wisconsin, and West Virginia.
All told, these 2 mergers, if both approved, would reduce competition in health insurance markets in nearly half the country (23 states total).
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Understanding How Fitness Affects Digestive Diseases
April 18th 2025Exercise is a powerful modulator of gut health in patients with gastrointestinal (GI) conditions, as moderate activity can ease gut inflammation, reduce colorectal cancer risk, and relieve constipation, while intense workouts may backfire, causing reflux, GI bleeding, or gut barrier disruption.
Read More
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
April 18th 2025Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.
Read More